Host: Typically expressed in Saccharomyces cerevisiae (yeast) for eukaryotic post-translational modifications .
| Parameter | Detail |
|---|---|
| Molecular Weight | ~30 kDa (varies by construct length) |
| Tag | Polyhistidine (His-tag) |
| Buffer | PBS pH 7.4, 50% glycerol |
| Applications | ELISA, enzymatic assays, structural studies |
Requires Mg²⁺ as a cofactor but lacks iron-sulfur clusters or SAM dependence .
Substrate specificity: Targets tRNAs with UNN anticodons (e.g., tRNAPhe, tRNATrp) .
Translational Regulation: MiaA-deficient H. pylori strains show reduced frameshifting fidelity and impaired stress response .
Pathogenesis: MiaA mutations in H. pylori correlate with altered redox homeostasis and antibiotic resistance (e.g., metronidazole), likely due to proteome-wide translational dysregulation .
Recombinant MiaA is recognized by sera from H. pylori-infected patients, suggesting diagnostic potential .
Immunization with recombinant H. pylori outer membrane proteins (e.g., Mr26kDa OMP) protects against infection, though MiaA-specific vaccine data remain limited .
Positively selected mutations in miaA among East Asian H. pylori strains suggest adaptive evolution to host environments .
KEGG: hpg:HPG27_1338
The miaA enzyme catalyzes the addition of a prenyl group onto the N⁶-nitrogen of adenosine-37 (A-37) in tRNAs that decode UNN codons, creating i⁶A-37 tRNA . This initial modification is essential as it serves as a prerequisite for subsequent methylthiolation by MiaB to create ms²i⁶A-37 . The bulky and hydrophobic ms²i⁶A-37 modification enhances tRNA interactions with target codons, promoting reading frame maintenance and translational fidelity . In bacteria such as Helicobacter pylori and Escherichia coli, this enzyme is functionally categorized as EC 2.5.1.75 (Dimethylallyl diphosphate:tRNA dimethylallyltransferase) .
Recombinant H. pylori miaA is commonly expressed in heterologous systems. Based on available protocols, the protein-coding sequence without signal peptide is amplified under standard PCR conditions from bacterial strains and subsequently cloned into expression vectors such as pQE2, pMal, pDS1, pET30, or pUC8 with appropriate restriction enzyme recognition sites . For expression, both mammalian cell systems and bacterial systems like E. coli have been used successfully. Purification typically involves affinity chromatography, with SDS-PAGE analysis confirming purity levels (generally >85%) . The recombinant protein may include various tag systems which are determined during the manufacturing process to facilitate purification .
Recombinant H. pylori miaA stability depends on several factors including storage state, buffer ingredients, and temperature. For optimal preservation, the following guidelines are recommended:
Avoid repeated freezing and thawing cycles
Store working aliquots at 4°C for up to one week
For long-term storage, add 5-50% glycerol (final concentration) and store aliquots at -20°C/-80°C
Liquid form typically maintains stability for approximately 6 months at -20°C/-80°C
Lyophilized form generally maintains stability for about 12 months at -20°C/-80°C
For reconstitution, it is recommended to briefly centrifuge the vial before opening and reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL .
The miaA enzyme has been identified as a significant contributor to bacterial pathogenicity through its role in translational regulation. Research with extraintestinal pathogenic E. coli (ExPEC) has demonstrated that MiaA is crucial to bacterial fitness and virulence . The enzyme's activity influences the bacterial proteome in several key ways:
Translation fidelity: MiaA-mediated tRNA modifications enhance codon-anticodon interactions, improving translational accuracy
Stress response modulation: Both ablation and overproduction of MiaA stimulate translational frameshifting and profoundly alter the bacterial proteome
Adaptive responses: MiaA levels shift in response to stress via post-transcriptional mechanisms, resulting in marked changes in the amounts of fully modified MiaA substrates
Regulatory control: MiaA acts as a regulatory nexus or "rheostat" that can realign global protein expression patterns to optimize cellular responses to changing environmental conditions
These findings in E. coli provide a model for understanding how similar mechanisms may function in H. pylori, potentially influencing its colonization efficiency and pathogenic capabilities in the gastric environment.
Researchers investigating miaA-mediated tRNA modifications typically employ a combination of techniques:
Mass spectrometry: To directly analyze modified nucleosides in tRNA molecules
Genetic approaches: Creating knockout or overexpression strains to observe phenotypic changes
Polysome profiling: To assess translation efficiency and fidelity
Proteomics: Quantitative proteomics to analyze how changes in miaA levels affect the cellular proteome
In vitro enzyme assays: Using purified recombinant enzyme with tRNA substrates to measure prenylation activity
For in vitro activity assays, researchers typically monitor the transfer of the prenyl group from dimethylallyl pyrophosphate (DMAPP) to the adenosine-37 position in tRNA. This can be measured through radioactive labeling, fluorescent detection, or mass spectrometry techniques that quantify either the modified tRNA product or the pyrophosphate byproduct of the reaction.
Recombinant H. pylori proteins, including potential virulence factors like miaA, can be leveraged in diagnostic immunoassays for detecting H. pylori infections. One example is the recomLine assay, which uses recombinant proteins immobilized on nitrocellulose membranes to detect serological immune responses in patient sera .
For development of such assays:
Purified recombinant antigens are applied to nitrocellulose membranes in specific concentrations
Optimal conditions (including detergent, dithiothreitol, and NaCl concentrations) are determined empirically to ensure optimal epitope presentation
Patient serum samples are applied at standardized dilutions (typically 1:100)
Antibody binding is detected using peroxidase-labeled secondary antibodies
Signal visualization is achieved through tetramethylbenzidine staining
While miaA itself is not currently among the most commonly used antigens for H. pylori diagnostics (which typically include CagA, VacA, GroEL, gGT, HcpC, and UreA), its potential as a diagnostic marker warrants investigation, especially given its role in bacterial pathogenicity.
Several challenges complicate structure-function studies of H. pylori miaA:
Protein solubility: Like many bacterial proteins, recombinant expression may result in inclusion bodies requiring denaturation/refolding strategies
Post-translational modifications: Ensuring proper folding and modifications in heterologous expression systems
Enzyme assay complexity: The prenylation reaction requires both tRNA substrates and prenyl donors, making activity assays technically challenging
Structural analysis difficulties: Obtaining high-resolution crystal structures can be challenging due to protein flexibility and substrate binding dynamics
To address these challenges, researchers often employ a multi-faceted approach including:
Expression with solubility-enhancing tags (as seen with HcpC, where an N-terminal maltose binding protein domain was introduced to increase solubility)
Site-directed mutagenesis to identify critical residues for catalysis and substrate binding
Comparative analyses with homologous enzymes from other bacterial species
Evidence from studies in ExPEC indicates that MiaA levels shift in response to stress via post-transcriptional mechanisms . This regulatory mechanism appears to function as follows:
Under stress conditions, bacteria adjust the specific types and levels of tRNA modifications
MiaA levels change in response to environmental stressors, resulting in altered amounts of fully modified MiaA substrates
These changes in tRNA modification patterns can orchestrate rapid responses to changing environmental conditions
The modified tRNAs affect translational efficiency in a codon-biased manner, leading to selective protein expression
This represents a post-transcriptional programmable mechanism that bacteria can use to facilitate beneficial changes in their proteomes under stress conditions. In H. pylori, this may be particularly relevant given the harsh acidic environment of the stomach where this pathogen must survive and establish infection.
While direct evidence specifically for H. pylori miaA and antibiotic resistance is limited in the provided search results, research with other bacterial species provides insights into potential connections:
Translational fidelity: Since miaA affects translational fidelity, mutations in this gene could potentially impact the expression of proteins involved in antibiotic resistance
Stress response: The role of miaA in bacterial stress responses suggests it may contribute to adaptive responses to antibiotic exposure
Proteome alterations: Changes in the bacterial proteome mediated by miaA activity could affect cellular processes targeted by antibiotics
This area represents an important direction for future research, particularly given the increasing prevalence of antibiotic-resistant H. pylori strains and the critical need for new therapeutic approaches.